Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1136158)
Received: 7 June 2018
Accepted: 20 September 2018
First Online: 11 October 2018
Ethics approval and consent to participate
: The SLATE II study protocol has been approved by the Boston University Institutional Review Board (H-37010) and the University of the Witwatersrand Human Research Ethics Committee (Medical) (171011). Written informed consent was obtained from all study subjects prior to enrollment.
: Not applicable.
: PDE is an employee of the Bill & Melinda Gates Foundation, which is funding this work. WDFV sits on antiretroviral initiation guideline committees, both South African and international. WDFV has accepted speaking honoraria from multiple manufacturers of antiretrovirals and is on several of their advisory boards. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.